Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period.
Chlamydia pneumoniae respiratory tract infections were studied in 512 male military conscripts (123 asthmatic and 389 non-asthmatic) taking part in 180-day service between July 2004 and July 2005 in Kajaani, Finland. Respiratory tract infections requiring a medical consultation were analysed prospectively. At baseline, at end of service, and during each episode of respiratory infection, blood samples were obtained for measurement of C. pneumoniae antibodies. Data concerning the clinical features of each infection episode were collected. Serological evidence of acute C. pneumoniae infection was found in 34 of the 512 conscripts with antibody data available, including 9.8% of the asthmatic subjects and 5.7% of the non-asthmatic subjects (p 0.111). A serological diagnosis could be made for 25 clinical episodes in 24 conscripts. The spectrum of respiratory tract infections included 13 episodes of mild upper respiratory tract infection and seven episodes of sinusitis, with five episodes involving asthma exacerbation. Two of three pneumonias were primary infections. Primary infections were diagnosed in five subjects, and re-infection/reactivation in 19 subjects, with the latter comprising 12 non-asthmatic subjects and seven asthmatic subjects (p 0.180). Prolonged infections were present in six asthmatic subjects and one non-asthmatic subject (p 0.001). A wide variety of respiratory tract infections, ranging from common cold to pneumonia, were associated with serologically confirmed C. pneumoniae infections. Infections were often mild, with common cold and sinusitis being the most common manifestations. Acute, rapidly resolved C. pneumoniae infections were equally common among asthmatic subjects and non-asthmatic subjects, whereas prolonged infections were more common among subjects with asthma.
Juvonen
R
R
Department of Otorhinolaryngology, Kainuu Central Hospital, Kajaani, Finland. raija.juvonen@kainuu.fi
Bloigu
A
A
Paldanius
M
M
Peitso
A
A
Silvennoinen-Kassinen
S
S
Harju
T
T
Leinonen
M
M
Saikku
P
P
D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood*; D001249:Asthma / Q000150:complications*; D023521:Chlamydophila Infections / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology; D016993:Chlamydophila pneumoniae / Q000276:immunology / Q000302:isolation & purification*; D005387:Finland / Q000453:epidemiology; D006801:Humans; D008297:Male; D008889:Military Personnel; D018410:Pneumonia, Bacterial / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology / Q000503:physiopathology; D015995:Prevalence; D011446:Prospective Studies; D012141:Respiratory Tract Infections / Q000382:microbiology; D012852:Sinusitis / Q000382:microbiology
D000907:Antibodies, Bacterial